Efficacy and safety of weekly liquid alendronate in Korean postmenopausal women with osteoporosis: a 12-month, multi-center, randomized trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Efficacy and safety of weekly liquid alendronate in Korean postmenopausal women with osteoporosis: a 12-month, multi-center, randomized trial ; volume:19 ; number:1 ; day:26 ; month:11 ; year:2024 ; pages:1-9 ; date:12.2024
Archives of osteoporosis ; 19, Heft 1 (26.11.2024), 1-9, 12.2024
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11657-024-01480-6
- URN
-
urn:nbn:de:101:1-2502272234379.124014466507
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baek, Seungjin
- Ahn, Seong Hee
- Hong, Namki
- Seo, Da Hea
- Hong, Seongbin
- Rhee, Yumie
- SpringerLink (Online service)
Ähnliche Objekte (12)
Postmenopausal osteoporosis
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
Quality of life in post-menopausal osteoporosis
Association between blood cadmium levels and the risk of osteopenia and osteoporosis in Korean post-menopausal women
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Concerns on modeling postmenopausal osteoporosis on young female rats
Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis
Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
Postmenopausal osteoporosis
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
Quality of life in post-menopausal osteoporosis
Association between blood cadmium levels and the risk of osteopenia and osteoporosis in Korean post-menopausal women
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Concerns on modeling postmenopausal osteoporosis on young female rats
Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis
Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
Postmenopausal osteoporosis
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
Quality of life in post-menopausal osteoporosis
Association between blood cadmium levels and the risk of osteopenia and osteoporosis in Korean post-menopausal women
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Concerns on modeling postmenopausal osteoporosis on young female rats
Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis